MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

MDT

86.38

+0.14%↑

A

113.77

-0.97%↓

VEEV

172.52

-1.27%↓

HQY

80.96

-2.52%↓

PHR.US

9.06

+0.33%↑

Search

Prometheus Biosciences Inc

Abrir

0

Visão Geral

Variação de preço das ações

24h

Atual

Mín

Máximo

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+0.04% upside

Prometheus Biosciences Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

6 de abr. de 2026, 23:17 UTC

Ganhos

Samsung Forecasts Record First-Quarter Operating Profit

6 de abr. de 2026, 23:00 UTC

Ações em Alta

Stocks to Watch: Health Insurers, Mawson, Owlet

6 de abr. de 2026, 22:13 UTC

Grandes Movimentos do Mercado

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 de abr. de 2026, 21:46 UTC

Aquisições, Fusões, Aquisições de Empresas

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 de abr. de 2026, 17:09 UTC

Grandes Movimentos do Mercado

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 de abr. de 2026, 16:56 UTC

Notícias Principais

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 de abr. de 2026, 14:47 UTC

Grandes Movimentos do Mercado

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 de abr. de 2026, 00:00 UTC

Notícias Principais

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 de abr. de 2026, 23:58 UTC

Conversa de Mercado
Notícias Principais

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 de abr. de 2026, 23:50 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 de abr. de 2026, 23:36 UTC

Conversa de Mercado

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 de abr. de 2026, 23:15 UTC

Conversa de Mercado

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 de abr. de 2026, 22:52 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

6 de abr. de 2026, 22:52 UTC

Conversa de Mercado

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 de abr. de 2026, 22:14 UTC

Conversa de Mercado

Correction to Live Cattle Futures Article

6 de abr. de 2026, 20:56 UTC

Conversa de Mercado

Mexican Private Consumption Fell in January -- Market Talk

6 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Energy & Utilities Roundup: Market Talk

6 de abr. de 2026, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

6 de abr. de 2026, 19:58 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

6 de abr. de 2026, 19:58 UTC

Conversa de Mercado

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 de abr. de 2026, 19:11 UTC

Conversa de Mercado

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 de abr. de 2026, 19:06 UTC

Conversa de Mercado

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 de abr. de 2026, 19:03 UTC

Conversa de Mercado

Global Energy Roundup: Market Talk

6 de abr. de 2026, 19:03 UTC

Conversa de Mercado

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 de abr. de 2026, 18:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 de abr. de 2026, 17:59 UTC

Conversa de Mercado
Notícias Principais

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 de abr. de 2026, 17:13 UTC

Aquisições, Fusões, Aquisições de Empresas

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 de abr. de 2026, 16:33 UTC

Conversa de Mercado

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 de abr. de 2026, 16:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

6 de abr. de 2026, 14:59 UTC

Ganhos

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Comparação entre Pares

Variação de preço

Prometheus Biosciences Inc Previsão

Preço-alvo

By TipRanks

0.04% parte superior

Previsão para 12 meses

Média 200 USD  0.04%

Máximo 200 USD

Mínimo 200 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Prometheus Biosciences Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

7 ratings

0

Comprar

7

Manter

0

Vender

Informação Financeira

$

help-icon Live chat